GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IsoPlexis Corp (NAS:ISO) » Definitions » Piotroski F-Score

IsoPlexis (IsoPlexis) Piotroski F-Score : 2 (As of May. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is IsoPlexis Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

IsoPlexis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for IsoPlexis's Piotroski F-Score or its related term are showing as below:

ISO' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 2
Current: 2

During the past 4 years, the highest Piotroski F-Score of IsoPlexis was 2. The lowest was 1. And the median was 2.


IsoPlexis Piotroski F-Score Historical Data

The historical data trend for IsoPlexis's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IsoPlexis Piotroski F-Score Chart

IsoPlexis Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
N/A N/A 1.00 2.00

IsoPlexis Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 N/A N/A N/A 2.00

Competitive Comparison of IsoPlexis's Piotroski F-Score

For the Medical Devices subindustry, IsoPlexis's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IsoPlexis's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IsoPlexis's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where IsoPlexis's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Net Income was -28.725 + -25.606 + -18.455 + -33.212 = $-106.00 Mil.
Cash Flow from Operations was -31.906 + -32.362 + -16.896 + -15.478 = $-96.64 Mil.
Revenue was 4.911 + 4.005 + 4.484 + 3.361 = $16.76 Mil.
Gross Profit was 2.555 + 2.076 + 2.257 + -7.814 = $-0.93 Mil.
Average Total Assets from the begining of this year (Dec21)
to the end of this year (Dec22) was
(187.472 + 176.112 + 152.966 + 134.852 + 109.068) / 5 = $152.094 Mil.
Total Assets at the begining of this year (Dec21) was $187.47 Mil.
Long-Term Debt & Capital Lease Obligation was $50.09 Mil.
Total Current Assets was $71.87 Mil.
Total Current Liabilities was $17.71 Mil.
Net Income was -15.559 + -20.554 + -20.199 + -25.257 = $-81.57 Mil.

Revenue was 3.234 + 4.289 + 4.193 + 5.542 = $17.26 Mil.
Gross Profit was 1.66 + 2.284 + 1.973 + 2.849 = $8.77 Mil.
Average Total Assets from the begining of last year (Dec20)
to the end of last year (Dec21) was
(123.605 + 123.146 + 118.91 + 99.872 + 187.472) / 5 = $130.601 Mil.
Total Assets at the begining of last year (Dec20) was $123.61 Mil.
Long-Term Debt & Capital Lease Obligation was $31.65 Mil.
Total Current Assets was $158.44 Mil.
Total Current Liabilities was $13.58 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

IsoPlexis's current Net Income (TTM) was -106.00. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

IsoPlexis's current Cash Flow from Operations (TTM) was -96.64. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec21)
=-105.998/187.472
=-0.5654071

ROA (Last Year)=Net Income/Total Assets (Dec20)
=-81.569/123.605
=-0.65991667

IsoPlexis's return on assets of this year was -0.5654071. IsoPlexis's return on assets of last year was -0.65991667. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

IsoPlexis's current Net Income (TTM) was -106.00. IsoPlexis's current Cash Flow from Operations (TTM) was -96.64. ==> -96.64 > -106.00 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=50.09/152.094
=0.32933581

Gearing (Last Year: Dec21)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec20 to Dec21
=31.646/130.601
=0.24231055

IsoPlexis's gearing of this year was 0.32933581. IsoPlexis's gearing of last year was 0.24231055. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec22)=Total Current Assets/Total Current Liabilities
=71.865/17.711
=4.05764779

Current Ratio (Last Year: Dec21)=Total Current Assets/Total Current Liabilities
=158.443/13.581
=11.6665194

IsoPlexis's current ratio of this year was 4.05764779. IsoPlexis's current ratio of last year was 11.6665194. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

IsoPlexis's number of shares in issue this year was 39.59. IsoPlexis's number of shares in issue last year was 39.036. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=-0.926/16.761
=-0.0552473

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=8.766/17.258
=0.50793835

IsoPlexis's gross margin of this year was -0.0552473. IsoPlexis's gross margin of last year was 0.50793835. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec21)
=16.761/187.472
=0.08940535

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec20)
=17.258/123.605
=0.13962218

IsoPlexis's asset turnover of this year was 0.08940535. IsoPlexis's asset turnover of last year was 0.13962218. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

IsoPlexis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

IsoPlexis  (NAS:ISO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


IsoPlexis Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of IsoPlexis's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


IsoPlexis (IsoPlexis) Business Description

Traded in Other Exchanges
N/A
Address
35 North East Industrial Road, Branford, CT, USA, 06405
IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer. It designed a platform to reveal functional protein biology and cellular signaling networks at single-cell resolution to accelerate the development of advanced medicines.
Executives
Nachum Shamir director 12212 TECHNOLOGY BLVD, AUSTIN TX 78727
John Strahley officer: Chief Financial Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Sean Mackay director, officer: Chief Executive Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rew Richard W. Ii officer: SVP, GC & Secretary 7000 WEST WILLIAM CANNON, BUILDING ONE, AUSTIN TX 78735
James R Heath director C/O ISOPLEXIS, 35 NE INDUSTRIAL RD, BRANFORD CT 06405
Michael Egholm director 1 FRANKLIN STREET, UNIT 3104, BOSTON MA 02110
Siddhartha Kadia director 7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Jason W. Myers director C/O ARCHERDX, INC., 2477 55TH STREET, SUITE 202, BOULDER CO 80301
John G. Conley director 396 GREAT MEADOWS RD, CONCORD MA 01742-1803
Gregory P. Ho director, 10 percent owner C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Peter Siesel officer: Chief Commercial Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Jing Zhou officer: Chief Scientific Officer 35 NORTH EAST INDUSTRIAL ROAD, BRANFORD CT 06405
Rajesh T. Khakhar officer: VP, Finance 35 NORTH INDUSTRIAL ROAD, BRANFORD CT 06405
Northpond Capital Gp, Llc 10 percent owner 4 BRATTLE STREET, FLOOR 3, CAMBRIDGE MA 02138
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003

IsoPlexis (IsoPlexis) Headlines

From GuruFocus

IsoPlexis Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 05-11-2022

IsoPlexis Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 05-21-2022